Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Dividend Payout Ratio : 0.23 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Clinuvel Pharmaceuticals Dividend Payout Ratio?

Clinuvel Pharmaceuticals's dividend payout ratio for the months ended in Dec. 2023 was 0.23.

The historical rank and industry rank for Clinuvel Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

CLVLF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.06 Max: 0.09
Current: 0.09

During the past 13 years, the highest Dividend Payout Ratio of Clinuvel Pharmaceuticals was 0.09. The lowest was 0.05. And the median was 0.06.

CLVLF's Dividend Payout Ratio is ranked better than
93.89% of 131 companies
in the Biotechnology industry
Industry Median: 0.43 vs CLVLF: 0.09

As of today (2024-04-27), the Dividend Yield % of Clinuvel Pharmaceuticals is 0.33%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Clinuvel Pharmaceuticals was 0.33%. The lowest was 0.05%. And the median was 0.11%.

Clinuvel Pharmaceuticals's Dividends per Share for the months ended in Dec. 2023 was $0.03.

During the past 12 months, Clinuvel Pharmaceuticals's average Dividends Per Share Growth Rate was 25.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 17.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Clinuvel Pharmaceuticals was 17.00% per year. The lowest was 7.70% per year. And the median was 12.35% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Clinuvel Pharmaceuticals Dividend Payout Ratio Historical Data

The historical data trend for Clinuvel Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals Dividend Payout Ratio Chart

Clinuvel Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Dividend Payout Ratio

Get a 7-Day Free Trial

0.05

0.06

0.07

Clinuvel Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial															0.22	-	0.17	-	0.23

Competitive Comparison of Clinuvel Pharmaceuticals's Dividend Payout Ratio

For the Biotechnology subindustry, Clinuvel Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinuvel Pharmaceuticals's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Clinuvel Pharmaceuticals's Dividend Payout Ratio falls into.

Clinuvel Pharmaceuticals Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Clinuvel Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jun. 2023 )	/	EPS without NRI (A: Jun. 2023 )
	=	0.027	/	0.397
	=	0.07

Clinuvel Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0.033	/	0.142
	=	0.23

Clinuvel Pharmaceuticals (OTCPK:CLVLF) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Clinuvel Pharmaceuticals Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLF) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

CLVLY:USA UR9:Germany CUV:Australia

Address

535 Bourke Street, Level 11, Melbourne, VIC, AUS, 3000

Website

https://www.clinuvel.com

Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.